- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Elutia Inc (ELUT)
Elutia Inc stock price live, this page displays NASDAQ ELUT stock exchange data. View the ELUT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Elutia Inc real time stock price chart below.
What Is the Elutia Inc Stock Price Today?
The Elutia Inc stock price today is 2.210.
What Is the Stock Symbol for Elutia Inc?
The stock symbol for Elutia Inc is ""ELUT.""
What Stock Exchange Does Elutia Inc Trade On?
Elutia Inc is listed and trades on the NASDAQ stock exchange.
Is Elutia Inc a Good Stock to Buy?
Determining whether Elutia Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ELUT quote. (ISIN: US05479K1060)
What Is the Elutia Inc Stock Price Today?
The Elutia Inc stock price today is 2.210.
What Is the Stock Symbol for Elutia Inc?
The stock symbol for Elutia Inc is ""ELUT.""
What Stock Exchange Does Elutia Inc Trade On?
Elutia Inc is listed and trades on the NASDAQ stock exchange.
Is Elutia Inc a Good Stock to Buy?
Determining whether Elutia Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ELUT quote. (ISIN: US05479K1060)
NASDAQ
Currency in USD
Fair Value
An estimate of a Elutia's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.180
2.400
52 wk Range
1.610
5.120
ELUT Scorecard
Full Analysis
Quickly burning through cash
Unusual trading volume
1/2
Fair Value
An estimate of a Elutia's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.1802.400
52 wk Range
1.6105.120
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ELUT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Elutia's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
6.500
Upside
+194.12%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Short term obligations exceed liquid assets
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Elutia Inc Company Profile
Elutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation and breast reconstruction in the United States. It operates in three segments: Device Protection, Women’s Health, and Cardiovascular. The company offers EluPro, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators; and CanGaroo, which mitigates complications derived from implantable electronic devices and shortcomings of synthetic envelopes. It also provides ProxiCor for cardiac tissue repair and pericardial closure; Tyke, an extracellular material that is used in the repair of cardiac structures for neonate and infant patients; and VasCure, a patch material used to repair or reconstruct the peripheral vasculature. In addition, the company offers SimpliDerm, which uses human acellular dermal matrices for tissue repair and reconstruction in various applications, such as sports medicine, hernia repair, trauma reconstruction, and breast reconstruction. It serves hospitals and healthcare facilities through its direct sales force, commercial partners, independent sales agents, and distributors. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland.
Elutia Inc Earnings Call Summary for Q2/2025
- Q2 2025 EPS loss of $0.26, missing $0.19 forecast; revenue at $6.3M, below $7.8M expectation; stock down 0.46% after hours
- Bio Envelope segment grew YoY to $3.5M; Elupro product showed 49% sequential growth; adjusted gross margin up 4 percentage points to 62.4%
- Focus on scaling Elupro through VAC and GPO expansion; developing NXT 41X breast reconstruction platform; increasing production capacity
- CEO emphasizes mission to 'humanize medicine'; company exploring strategic business development opportunities
- Analysts inquired about Elupro production bottlenecks and hospital ordering patterns; company reports no significant issues and predictable demand
Last Updated: 14/08/2025, 23:00
Read Full TranscriptCompare ELUT to Peers and Sector
Metrics to compare | ELUT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipELUTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.4x | −3.5x | −0.6x | |
PEG Ratio | −0.07 | −0.04 | 0.00 | |
Price/Book | −2.2x | 2.3x | 2.6x | |
Price / LTM Sales | 4.0x | 7.7x | 3.3x | |
Upside (Analyst Target) | 170.8% | 79.7% | 38.7% | |
Fair Value Upside | Unlock | 4.6% | 5.1% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 6.500
(+194.12% Upside)
Earnings
Latest Release
Aug 14, 2025
EPS / Forecast
-0.26 / -0.19
Revenue / Forecast
6.26M / 7.80M
People Also Watch
FAQ
What Stock Exchange Does Elutia Trade On?
Elutia is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Elutia?
The stock symbol for Elutia is "ELUT."
What Is the Elutia Market Cap?
As of today, Elutia market cap is 90.87M.
What Is Elutia's Earnings Per Share (TTM)?
The Elutia EPS (TTM) is -0.58.
When Is the Next Elutia Earnings Date?
Elutia will release its next earnings report on 16 Nov 2025.
From a Technical Analysis Perspective, Is ELUT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Elutia Stock Split?
Elutia has split 0 times.
How Many Employees Does Elutia Have?
Elutia has 51 employees.
What is the current trading status of Elutia (ELUT)?
As of 28 Aug 2025, Elutia (ELUT) is trading at a price of 2.21, with a previous close of 2.40. The stock has fluctuated within a day range of 2.18 to 2.40, while its 52-week range spans from 1.61 to 5.12.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.